TIN Temple Inland

Today, www.BollingerReport.com introduced featured coverage of InterMune, Inc. (NASDAQ: ITMN) and Temple-Inland, Inc. (NYSE: TIN). Full research reports are available to readers at: www.BollingerReport.com/index.php?sm1=ITMN&sm2=TIN.

Upcoming macro-economic 'tides of influence' are buoyed by crisis both home and abroad. Spanish and Italian yields continue to climb as efforts by the European Central Bank have stopped short of establishing sovereign bond guarantees for any one country. The result is historic yields and a grave concern for the solvency of interbank lending. Markets were drawn to concerns over domestic policy stalemates producing downgrade risks. Despite the situation, there continues to be unique value and opportunity found within careful discretion.

Bollinger Report screened and selected InterMune, Inc. for its current position within the healthcare industry. InterMune, Inc. (InterMune) is a biotechnology company focused on the research, development and commercialization of therapies in pulmonology and fibrotic diseases. In pulmonology, the Company is focused on therapies for the treatment of idiopathic pulmonary fibrosis (IPF), which is a lung disease. A copy of this report featuring InterMune, Inc. (NASDAQ: ITMN) is available at: www.BollingerReport.com/index.php?sm1=ITMN.

Bollinger Report is featuring Temple-Inland, Inc. for its changing role within the consumer goods industry. Temple-Inland Inc. manufactures corrugated packaging and building products, which the Company considers as two separate operating segments. The Company's vertically integrated corrugated packaging operation includes seven mills and 59 converting facilities. Temple-Inland Inc. To download researches and analysis on Temple-Inland, Inc. (NYSE: TIN) we welcome investors to visit: www.BollingerReport.com/index.php?sm2=TIN.

About Bollinger Report Bollinger Report has come to be known among its peers as a trusted source of information for both investors and technical traders. Our online content is continually updated, bringing fresh new researches and analyses to the investment community.

Contact: Martin Schwartz Email Contact www.BollingerReport.com